Children’s National Hospital Receives $96 Million for Rare Brain Tumor Research & Care

Children’s National received a $96 million investment from an anonymous donor family to transform rare childhood brain tumor research and care. This is one of the largest donations in the hospital’s history. The investment allows us to recruit more top talent and advance the most promising research for safer, more effective treatments. It will also elevate standards of care to help children with rare brain tumors thrive for a lifetime. 

 

“This incredible partnership will lift up one of the nation’s top pediatric brain tumor programs into the stratosphere,” said Kurt Newman, M.D., president and CEO of Children's National. “It will immediately propel our best-in-class research and care, allowing us to bring new therapies to children with brain tumors. This fundamentally changes the healthcare journey and long-term outcomes for children and their families.”

 

Brain tumors are the most common solid tumors affecting children. They are especially challenging in kids because their brains are still developing. The disease and current treatments can put them at risk for lifelong complications. 

 

The anonymous donor family brings a depth of compassion for children facing rare and often challenging diagnoses. Their partnership will advance the hospital’s leadership and work that generous supporters over the years created to benefit kids with rare brain tumors. 

 

“Delivering world-class care to every child who needs it requires partnerships and this donor family’s generosity is remarkable,” said Horacio Rozanski, chair of the Children’s National Board of Directors. “Pairing their philanthropy with our brightest minds in research and care will spark the development of new and better ways to care for children with rare brain tumors.”

 

Learn more about what the funding will make possible.